Philadelphia Pharmaceuticals Company reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was JOD 4.02 million compared to JOD 3.9 million a year ago. Net income was JOD 0.40607 million compared to JOD 0.317529 million a year ago.

Basic earnings per share from continuing operations was JOD 0.054 compared to JOD 0.042 a year ago.